NICOLE PALMIERI: Open Payments
NPI 1538716535 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 60 payments from 16 companies in 2025. Trend: 2023 $1,846 · 2024 $1,615 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $372 |
| Alkermes, Inc. | 11 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $158 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Lundbeck LLC | 4 | $65 |
| Braeburn Inc. | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Bausch Health US, LLC | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: Auvelity, CAPLYTA, ARISTADA, REXULTI, FANAPT, LYBALVI, BRIXADI, Qelbree.
Industry payments across NJ — which companies pay providers there.
